French biotech Abivax has been the subject of intense takeover speculation for months. But a spokesperson denied a report by La Lettre that AstraZeneca was ...

AstraZeneca PLC (NYSE:AZN) is one of Goldman Sachs top healthcare stocks. On March 9, AstraZeneca PLC (NYSE:AZN) and Daiichi Sankyo secured Priority Review in the US for Enhertu, their candidate drug ...

The FDA's cancer advisors will discuss AstraZeneca’s application for the oral SERD camizestrant in breast cancer and the AKT ...

Astrazeneca (AZN) closed the most recent trading day at $189.90, moving -1.35% from the previous trading session. The stock's performance was behind the S&P 500's daily loss of 0.61%. Meanwhile, the ...

As AstraZeneca kicks off the third year of its hockey-themed “Get Body Checked Against Cancer” campaign, the pharma has tapped two celebs known for their work both on and off the ice. | As AstraZeneca ...

In a scathing rebuke (PDF) to AstraZeneca, the FDA cited “critical data quality issues that affect key analyses, including the primary endpoint” within a dataset for Saphnelo (anifrolumab) for the ...

British drugmaker AstraZeneca Plc AZN has emerged as the leading contender to acquire French biotech Abivax SA ABVX, ...

Exxon Mobil leads fresh analyst reports as Permian and Guyana output power growth, while Palantir's AI platforms and AstraZeneca's drug pipeline highlight key momentum.

AstraZeneca's share price looks anchored to an outdated story — and the latest results suggest the market may be missing something. The post Below £151, here’s why AstraZeneca’s share price looks a ...

Launched by AstraZeneca, Secaro and ERM, the Clean Heat Program aims to close critical gaps in heat decarbonisation across global supply chains ...

By Sabrina Valle NEW YORK, March 12 (Reuters) - Biotechnology company Abivax on Thursday dismissed a report by French media ...